Blood sugar tracker may extend life in brain cancer patients

NCT ID NCT07091864

First seen Sep 30, 2025 · Last updated May 12, 2026 · Updated 28 times

Summary

This study tests whether a continuous glucose monitor (CGM) can help people with glioblastoma manage their blood sugar and possibly live longer. High blood sugar during treatment is linked to worse outcomes, and steroids often cause it. The CGM device tracks glucose in real time, allowing for quicker treatment. The trial will enroll 116 adults with newly diagnosed glioblastoma.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA, IDH-WILDTYPE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mayo Clinic in Arizona

    NOT_YET_RECRUITING

    Phoenix, Arizona, 85054, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-••••

  • Mayo Clinic in Florida

    NOT_YET_RECRUITING

    Jacksonville, Florida, 32224, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-••••

  • Mayo Clinic in Rochester

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.